These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11994701)

  • 1. Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction.
    Dahlén B; Roquet A; Inman MD; Karlsson O; Naya I; Anstrén G; O'Byrne PM; Dahlén SE
    J Allergy Clin Immunol; 2002 May; 109(5):789-93. PubMed ID: 11994701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics.
    Roquet A; Dahlén B; Kumlin M; Ihre E; Anstrén G; Binks S; Dahlén SE
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1856-63. PubMed ID: 9196086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of zafirlukast on repetitive exercise-induced bronchoconstriction: the possible role of leukotrienes in exercise-induced refractoriness.
    Dessanges JF; Préfaut C; Taytard A; Matran R; Naya I; Compagnon A; Dinh-Xuan AT
    J Allergy Clin Immunol; 1999 Dec; 104(6):1155-61. PubMed ID: 10588995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory basis of exercise-induced bronchoconstriction.
    Hallstrand TS; Moody MW; Wurfel MM; Schwartz LB; Henderson WR; Aitken ML
    Am J Respir Crit Care Med; 2005 Sep; 172(6):679-86. PubMed ID: 15947280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.
    Reicin A; White R; Weinstein SF; Finn AF; Nguyen H; Peszek I; Geissler L; Seidenberg BC
    Arch Intern Med; 2000 Sep; 160(16):2481-8. PubMed ID: 10979060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma].
    Benitez HH; Arvizu VM; Gutiérrez DJ; Fogelbach GA; Castellanos Olivares A; Vázquez Nava F; Velázquez HC; González Pérez Mdel C; Mora Nieto A; Rodríguez EC
    Rev Alerg Mex; 2005; 52(2):90-5. PubMed ID: 16158782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of single-dose montelukast and loratadine on exercise-induced bronchospasm in children.
    Peroni DG; Piacentini GL; Pietrobelli A; Loiacono A; De Gasperi W; Sabbion A; Micciolo R; Boner AL
    Eur Respir J; 2002 Jul; 20(1):104-7. PubMed ID: 12166555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children.
    Pearlman DS; Ostrom NK; Bronsky EA; Bonuccelli CM; Hanby LA
    J Pediatr; 1999 Mar; 134(3):273-9. PubMed ID: 10064661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The leukotriene receptor antagonist zafirlukast inhibits sulfur dioxide-induced bronchoconstriction in patients with asthma.
    Lazarus SC; Wong HH; Watts MJ; Boushey HA; Lavins BJ; Minkwitz MC
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1725-30. PubMed ID: 9412547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma.
    Laitinen A; Lindqvist A; Halme M; Altraja A; Laitinen LA
    J Allergy Clin Immunol; 2005 Feb; 115(2):259-65. PubMed ID: 15696079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma--A comparison with leukotriene D4 induced broncoconstriction.
    Schelfhout V; Van De Velde V; Pauwels R; Joos G
    Pulm Pharmacol Ther; 2008; 21(2):276-84. PubMed ID: 17611132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and duration of action of the antileukotriene zafirlukast on cold air-induced bronchoconstriction.
    Richter K; Jörres RA; Magnussen H
    Eur Respir J; 2000 Apr; 15(4):693-9. PubMed ID: 10780761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of zafirlukast on methacholine and ultrasonically nebulized distilled water challenge in patients with mild asthma.
    Carratù P; Morelli N; Freire AX; Pugazhenthi M; Guerra S; Umberger R; Allegra L
    Respiration; 2003; 70(3):249-53. PubMed ID: 12915743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise-induced asthma: is there still a case for histamine?
    Anderson SD; Brannan JD
    J Allergy Clin Immunol; 2002 May; 109(5):771-3. PubMed ID: 11994697
    [No Abstract]   [Full Text] [Related]  

  • 16. Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma.
    Kelloway JS
    Ann Pharmacother; 1997 Sep; 31(9):1012-21. PubMed ID: 9296243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of desloratadine on patients with allergic rhinitis and exercise-induced bronchoconstriction: a placebo controlled study.
    Manjra AI; Nel H; Maharaj B
    J Asthma; 2009 Mar; 46(2):156-9. PubMed ID: 19253122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma.
    Kemp JP; Minkwitz MC; Bonuccelli CM; Warren MS
    Chest; 1999 Feb; 115(2):336-42. PubMed ID: 10027429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype.
    Lipworth BJ; Dempsey OJ; Aziz I; Wilson AM
    Am J Med; 2000 Aug; 109(2):114-21. PubMed ID: 10967152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials.
    Barnes NC; Miller CJ
    Thorax; 2000 Jun; 55(6):478-83. PubMed ID: 10817796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.